FdaApplication
ANDA 209921
Identifiers
- fda_app_no: ANDA209921
Properties
| Property | Value |
|---|---|
| applicant_name | ANI PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2019-05-07 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LUXZYLA | PENICILLAMINE | 250MG | CAPSULE;ORAL |
1 product